Letters to the Editor
Clinical Pharmacology & Therapeutics (2005) 77, 453–454; doi: 10.1016/j.clpt.2005.01.021
Traditional Aqueous Kava Extracts Inhibit Cytochrome P450 1A2 in Humans: Protective Effect Against Environmental Carcinogens?
Stefan Russmann MD1, Bernhard H. Lauterburg MD1, Yann Barguil PharmD2, Erwan Choblet MD2, Pierre Cabalion PhD3, Katharina Rentsch PhD4 and Markus Wenk PhD5
- 1Department of Clinical Pharmacology, University of Bern, Bern, Switzerland
- 2New Caledonia Hospital Center, Nouméa, New Caledonia
- 3Institute of Research and Development, Nouméa, New Caledonia
- 4Institute of Clinical Chemistry, University Hospital Zürich, Zürich, Switzerland
- 5Department of Clinical Pharmacology & Toxicology, University of Basel, Basel, Switzerland
Correspondence: , E-mail: russmann@bu.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Traditional aqueous kava extracts inhibit CYP4501A2 in humansClinical Pharmacology & Therapeutics null
Supplementation With Goldenseal (Hydrastis canadensis), but not Kava Kava (Piper methysticum), Inhibits Human CYP3A Activity In VivoClinical Pharmacology & Therapeutics Article Response
